# Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients

> **NCT02548923** · PHASE4 · COMPLETED · sponsor: **University of Tennessee Graduate School of Medicine** · enrollment: 57 (actual)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02548923
- **Lead sponsor:** University of Tennessee Graduate School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548923, "Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02548923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
